Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled DMT for Depression with Partial Response
NCT06094907Phase 2Completed
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DMT in major depressive disorder (MDD), sponsored by Universidade Federal do Rio Grande do Norte. Started Oct 2023; status: completed.
02
Drugs
DMT
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06094907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06094907.